Summary
- Current Price
- As of today, NEUP price is $4.35, up +1.87% on
- Current Price All-Time High
- NEUP price is currently -98.35% below its historical high of $264.00 set on
- Market Cap
- NEUP current market cap is $23M, up +163.63% over the past 365 days
- PE Ratio
- NEUP current PE ratio is 3.18
- Revenue
- NEUP current annual revenue is $15.65M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for NEUP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Neuphoria Therapeutics Inc. |
| Ticker | NASDAQ: NEUP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | neuphoriatx.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.35 | ||
| Price, 1D Change | +1.87% | |
| $23M | ||
| - | ||
| 3.18 | ||
| 0.61 | ||
| $16M | ||
| Revenue, 1Y Change | +100.00% | |
| -$0.23 | ||
| EPS, 1Y Change | +77.59% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BNOX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.23 | ||
| EPS Estimate | N/A | -$4.07 |
| EPS Est. Change | N/A | -1,686.65% |
| $15.65M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $4.35 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +60.92% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.93 | -$0.23 | +75.37% | |
| -$4.07 | N/A | -1,686.65% | |
| -$3.85 | N/A | -1,587.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.85M | $15.65M | -1.29% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -13.86% | ||
| -90.71% | ||
| +163.63% | ||
| -99.97% | ||
| +100.00% | ||
| +8,084.83% | ||
| +77.59% | ||
| +89.15% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $4.35 | ||
| $7.12 | ||
| SMA 200 vs Price | +63.68% | |
| $4.02 | ||
| SMA 50 vs Price | -7.51% | |
| 0.61 | ||
| $0.17 | ||
| 61.45 | ||
| 50.44% | ||
| 125.95% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $15.65M | ||
| -$0.23 | ||
| $14.99M | ||
| 95.76% | ||
| -$1.13M | ||
| -7.22% | ||
| -$369.60K | ||
| -2.36% | ||
| -$466.20K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 3.56 | ||
| 3.56 | ||
| - | ||
| - | ||
| -6.40 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 3.18 | ||
| 1.56 | ||
| 0.79 | ||
| 0.29 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $19.00M | ||
| $14.29M | ||
| $28.59M | ||
| $15.04M | ||
| $9.59M | ||
| $4.22M | ||
| $149.10K | ||
| $149.10K | ||
| $1.15M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $16.02M | ||
| $16.12M | ||
| $662.90K | ||
| $0.00 | ||
| $662.90K | ||
| $0.00 | ||
| -$468.40K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $77.20K | ||
| $0.00 | ||
| $1.53M | ||
| $0.00 | ||
| $77.20K |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with NEUP
FAQ
What is the ticker symbol for Neuphoria Therapeutics Inc.?
The ticker symbol for Neuphoria Therapeutics Inc. is NASDAQ:NEUP
Does Neuphoria Therapeutics Inc. pay dividends?
No, Neuphoria Therapeutics Inc. does not pay dividends
What sector is Neuphoria Therapeutics Inc. in?
Neuphoria Therapeutics Inc. is in the Healthcare sector
What industry is Neuphoria Therapeutics Inc. in?
Neuphoria Therapeutics Inc. is in the Biotechnology industry
What country is Neuphoria Therapeutics Inc. based in?
Neuphoria Therapeutics Inc. is headquartered in United States
When did Neuphoria Therapeutics Inc. go public?
Neuphoria Therapeutics Inc. initial public offering (IPO) was on December 16, 2021
Is Neuphoria Therapeutics Inc. in the S&P 500?
No, Neuphoria Therapeutics Inc. is not included in the S&P 500 index
Is Neuphoria Therapeutics Inc. in the NASDAQ 100?
No, Neuphoria Therapeutics Inc. is not included in the NASDAQ 100 index
Is Neuphoria Therapeutics Inc. in the Dow Jones?
No, Neuphoria Therapeutics Inc. is not included in the Dow Jones index
When was Neuphoria Therapeutics Inc. last earnings report?
Neuphoria Therapeutics Inc.'s most recent earnings report was on November 14, 2025
When does Neuphoria Therapeutics Inc. report earnings?
The date for Neuphoria Therapeutics Inc.'s next earnings report has not been announced yet
Data Sources & References
- NEUP Official Website www.neuphoriatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1191070/000119312525223338/0001193125-25-223338-index.htm
- NEUP Profile on Yahoo Finance finance.yahoo.com/quote/NEUP
- NEUP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/neup